News Digest / Ticker: VRDN

Ticker: VRDN

08:14am, Wednesday, Aug 06, 2025

Viridian Therapeutics Reports High Q2 2025 Losses Amid Progress in Rare Disease Therapies

Viridian Therapeutics, Inc. (NASDAQ: VRDN) - Q2 2025 Financial Overview Viridian Therapeutics reported its financial results for the quarter ending June 30, 2025, highlighting both significant operational achievements and challenges. The company's focus lies in developing therapies for rare disea...

08:00am, Tuesday, May 06, 2025

Viridian Therapeutics Reports Q1 Losses Amid Ongoing Development for Rare Disease Treatments

08:48am, Tuesday, Sep 10, 2024

Premarket Movers: Apple Drops, Oracle Soars